StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$49.75−0.06 (-0.12%)

Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%

Qiagen gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 62.2%, against 48.9% the year before. The highest annual figure on record is 67.2% in fiscal 2008.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202562.2%+13.3
FY2024Dec 31, 202448.9%−13.9
FY2023Dec 31, 202362.8%−1.9
FY2022Dec 31, 202264.7%+0.2
FY2021Dec 31, 202164.4%−1.5
FY2020Dec 31, 202065.9%+0.1
FY2019Dec 31, 201965.9%−0.8
FY2018Dec 31, 201866.6%+1.6
FY2017Dec 31, 201765.1%+2.0
FY2016Dec 31, 201663.1%−1.4
FY2015Dec 31, 201564.5%+0.2
FY2014Dec 31, 201464.3%+1.7
FY2013Dec 31, 201362.6%−3.1
FY2012Dec 31, 201265.7%+1.6
FY2011Dec 31, 201164.1%−1.7
FY2010Dec 31, 201065.8%−0.3
FY2009Dec 31, 200966.1%−1.1
FY2008Dec 31, 200867.2%–

More Qiagen figures

See a number that looks wrong?